Trial Profile
Efficacy and distinctive effects of atypical antipsychotics on cognitive symptoms in dual diagnosis - A phase IIIb, randomized, open-labelled study to evaluate the cognitive effects of quetiapine XR and olanzapine in patients with schizophrenia and substance abuse
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 24 Aug 2011
Price :
$35
*
At a glance
- Drugs Quetiapine (Primary) ; Olanzapine
- Indications Schizophrenia
- Focus Therapeutic Use
- 24 Aug 2011 New trial record